Taiwan FDA registration 5fa78908c65bf51ed1e73444780b162e

EKang blood glucose/cholesterol/heme monitoring system

TW: 易康 血糖/膽固醇/血紅素 監測系統
Taiwan flagTaiwan·Risk Class 2·Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd·Registered Dec 06, 2017 – Dec 06, 2027Active
Registration details
Analysis ID
5fa78908c65bf51ed1e73444780b162e
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
This product is only for in vitro testing, measured with fresh fingertip microvascular whole blood to quantitatively detect blood sugar, cholesterol and heme content. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns.
Product Type (Level 1)
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1345 Glucose Test System;; B.7500 Heme analysis of whole blood
Import Information
Domestic;; Contract manufacturing
Dates and status
Registration Date
Dec 06, 2017
Expiry Date
Dec 06, 2027
About this record

Access comprehensive regulatory information for EKang blood glucose/cholesterol/heme monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5fa78908c65bf51ed1e73444780b162e and manufactured by Naohara Biotechnology Co., Ltd.;; Yuxin Biotechnology Co., Ltd. The authorized representative in Taiwan is EASY LIFE GREEN TECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices